Barbara Ann Karmanos Cancer Institute is a clinical research site located in Detroit, Michigan, United States 48201-1379.
Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.
Barbara Ann Karmanos Cancer Institute has participated in 589 clinical trials with 51 currently active.
Therapeutic areas: Lymphoma, Platinum-resistant Ovarian Cancer, Breast Cancer.
Sponsors: Children's Oncology Group, Genmab, Alliance for Clinical Trials in Oncology.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Michigan · View every site in Detroit
Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Barbara Ann Karmanos Cancer Institute has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Barbara Ann Karmanos Cancer Institute has 589 clinical trials on record, with 51 currently active. Their work covers Lymphoma, Platinum-resistant Ovarian Cancer, Breast Cancer.
Barbara Ann Karmanos Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.